Intron-Binding Protein Of 160 KDa Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-87631
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the C-terminal region of Human Intron-Binding Protein Of 160 KDa. Peptide sequence: DTTPSETGATSTPEAIPALSETTPTVVGAVSAPAEANTPQDATSAPEETK The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for Intron-Binding Protein Of 160 KDa Antibody
Western Blot: Intron-Binding Protein Of 160 KDa Antibody [NBP2-87631]
Western Blot: Intron-Binding Protein Of 160 KDa Antibody [NBP2-87631] - WB Suggested Anti-AQR Antibody. Titration: 1.0 ug/ml. Positive Control: MCF7 Whole CellAQR is supported by BioGPS gene expression data to be expressed in MCF7Applications for Intron-Binding Protein Of 160 KDa Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Intron-Binding Protein Of 160 KDa
Alternate Names
AQR, aquarius homolog (mouse), FSAP164, Functional Spliceosome-Associated Protein 164, IBP160, Intron-Binding Protein Aquarius
Gene Symbol
AQR
Additional Intron-Binding Protein Of 160 KDa Products
Product Documents for Intron-Binding Protein Of 160 KDa Antibody
Product Specific Notices for Intron-Binding Protein Of 160 KDa Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...